BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire
*MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE)* — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual..
*MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE)* — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual..
The infectious disease therapeutics market size was valued at USD 70.1 Billion in 2023 and is expected to reach a market size of..
*Mainz, Germany, March 20, 2024 (GLOBE NEWSWIRE)* – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced..